Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group.
暂无分享,去创建一个
M. Blaufox | N. Shulman | C. Ford | W. Hall | D. Simon | H. Langford | K. Schneider
[1] H. Taussky,et al. ON THE COLORIMETRIC DETERMINATION OF CREATININE BY THE JAFFE REACTION , 1945 .
[2] R. Hare,et al. Endogenous Creatinine in Serum and Urine.∗ † , 1950, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[3] M D KOGEL,et al. The Albert Einstein College of Medicine. , 1957, Journal of medical education.
[4] F. Ederer,et al. Maximum utilization of the life table method in analyzing survival. , 1958, Journal of chronic diseases.
[5] H. Grady,et al. Determination of creatinine by means of automatic chemical analysis. , 1960, Technical bulletin of the Registry of Medical Technologists. American Society of Clinical Pathologists. Registry of Medical Technologists.
[6] D. Baldwin,et al. The Kidney in Essential Hypertension Victim or Culprit , 1966, Circulation.
[7] Strother H. Walker,et al. Estimation of the probability of an event as a function of several independent variables. , 1967, Biometrika.
[8] Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. , 1970, JAMA.
[9] O. Paul. Risks of mild hypertension: a ten-year report , 1971, British heart journal.
[10] References , 1971 .
[11] The kidney as a target organ in hypertension. , 1976, Geriatrics.
[12] Blood pressure studies in 14 communities. A two-stage screen for hypertension. , 1977, JAMA.
[13] Race, education and prevalence of hypertension. , 1977, American journal of epidemiology.
[14] H. Menduke,et al. An areawide survey of treated end-stage renal disease. , 1978, American journal of public health.
[15] W. Pettinger,et al. Renal function during long-term treatment of hypertension with minoxidil: comparison of benign and malignant hypertension. , 1980, Annals of internal medicine.
[16] R. Hiatt,et al. Characteristics of patients referred for treatment of end-stage renal disease in a defined population. , 1982, American journal of public health.
[17] S. Rostand,et al. Racial differences in the incidence of treatment for end-stage renal disease. , 1982, The New England journal of medicine.
[18] A. Doyle,et al. The Australian Therapeutic Trial in Mild Hypertension. , 1982, Nephron.
[19] B. Tung,et al. Nosological coding of cause of death. , 1983, American journal of epidemiology.
[20] Epidemiology of end stage renal disease and implications for public policy. , 1984, Public health reports.
[21] P. Eggers,et al. The Medicare experience with end-stage renal disease: Trends in incidence, prevalence, and survival , 1984, Health care financing review.
[22] J. Abernethy. The Australian therapeutic trial in mild hypertension. , 1984, Hypertension.
[23] The public cost of kidney disease. , 1984, Social work in health care.
[24] L. Wilhelmsen,et al. Heart and kidney involvement during antihypertensive treatment. Results from the primary preventive trial in Göteborg, Sweden. , 2009, Acta medica Scandinavica.
[25] C. Ford,et al. Ascertainment of vital status through the National Death Index and the Social Security Administration. , 1985, American journal of epidemiology.
[26] J. Stamler,et al. Need to prevent and control high-normal and high blood pressure, particularly so-called "mild" hypertension: epidemiological and clinical data. , 1985, Preventive medicine.
[27] M. Blaufox,et al. Apparent prevalence of curable hypertension in the Hypertension Detection and Follow-up Program. , 1985, Archives of internal medicine.
[28] The kidney in essential hypertension. , 1985, Contributions to nephrology.
[29] W. Blythe,et al. Natural history of hypertension in renal parenchymal disease. , 1985, American Journal of Kidney Diseases.
[30] N W Shock,et al. Longitudinal Studies on the Rate of Decline in Renal Function with Age , 1985, Journal of the American Geriatrics Society.
[31] End-stage renal disease in Michigan. Incidence, underlying causes, prevalence, and modalities of treatment. , 1985, American journal of nephrology.
[32] J. Neugarten,et al. Treatment of hypertension in renal disease. , 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[33] Results and implications of the Hypertension Detection and Follow-up Program. , 1986, Progress in cardiovascular diseases.
[34] B. Davis,et al. The Hypertension Detection and Follow-up Program design, methods, and baseline characteristics and blood pressure response of the study population. , 1986, Progress in cardiovascular diseases.
[35] The end-stage renal disease program: here are some of the data. , 1987, JAMA.
[36] M. Pauly,et al. Survival analysis of patients undergoing dialysis. , 1987, JAMA.
[37] P. Eggers,et al. Effect of transplantation on the Medicare end-stage renal disease program. , 1988, The New England journal of medicine.